Press release
Endovascular Treatment Devices Market Exclusive Report on the Latest Revenue and Future Scope
The global Endovascular Treatment Devices market is estimated to reach over USD 5.77 billion by 2031, exhibiting a CAGR of 8.52% during the forecast period.
The Endovascular Treatment Devices Market Size is valued at 3.00 Billion in 2022 and is predicted to reach 6.38 Billion by the year 2031 at a 9.08 % CAGR during the forecast period for 2024-2031.
Request For Free Sample Report: https://www.insightaceanalytic.com/request-sample/1364
Endovascular surgery is an advanced, minimally invasive procedure used to treat medical conditions that impact the blood arteries, such as aneurysms, bulging or "ballooning" blood vessels. The treatment begins with a body incision to gain access to the blood vessels. Then, to enable medication withdrawal or delivery from the patient's bloodstream, a flexible plastic tube, stents, or catheter is inserted into the injured blood vessel. Chemotherapy, long-term intravenous nourishment, intravenous antibiotic therapy, and blood transfusions are a few therapies that use endovascular therapeutic devices. Due to factors like an ageing population, an increase in the prevalence of cardiovascular diseases, technologically advanced endovascular products, and increased spending on research and development by market players, the market for endovascular treatment devices is predicted to expand during the forecast period.
Market expansion is being restrained by the high cost of endovascular procedures, a lack of knowledge in developing economies, and a lack of skilled surgeons to perform the functions. The use of endovascular treatment devices has expanded as a result of breakthrough product launches and rising healthcare spending, which is stimulating research and development.
List of Prominent Players in the Endovascular Treatment Devices Market:
Cardinal Health
Endospan
Geting AB
Bosten Scientific Corporation
Inspire MD
Japan Lifeline Co., Ltd.
Medtronic
Lombord Medical
Penumbra, Inc.
Terumo Corporation
Market Dynamics:
Drivers-
In the upcoming years, market growth will also be fueled by the high prevalence of abdominal aortic aneurysms, which are more common in men, and a potential rise in demand for minimally invasive techniques like endovascular surgery. The majority of abdominal aortic aneurysms (AAA), which mainly afflict men, range from 4% to 8%, according to screening studies. Due to the growing global geriatric population, AAA prevalence is high in the ageing population and could become substantial in the future. The market for endovascular treatment devices will proliferate due to rapid technological advancement and considerable improvements in minimally invasive surgery.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1364
Challenges:
Some of the main obstacles in the global market for endovascular treatment devices are anticipated to include the high cost associated with using new endovascular therapy devices, a lack of awareness in economically underdeveloped countries, and the US's strict tax regulations on medical products.
Regional Trends:
The North America Endovascular Treatment Devices market is expected to register a significant market share in revenue and is projected to grow at a high CAGR shortly. The market has grown due to an increase in surgical operations and medical professionals' desire for these devices, which has led big businesses to concentrate on developing cutting-edge medical devices in these countries. The region's endovascular therapy devices market will grow due to the obesity and diet epidemics, as well as the development of new products due to prominent manufacturers. Besides, Asia Pacific had a substantial share in the endovascular treatment devices market. Increased medical advancements have contributed to the endovascular treatment devices market revenue growth in this area, leading to continuing industry expansion. Increased R&D efforts and medical advances made by significant participants in the region's nations can also be credited with growth.
Recent Developments:
In November 2021, Endospan released 30-day and 1-year safety and performance results for its off-the-shelf endovascular Nexus graft devices, designed to treat thoracic aortic lesions involving the aortic arch.
In September 2021, Boston Scientific Corporation agreed to buy Devoro Medical, the developer of the WOLF Thrombectomy Platform, to expand its interventional techniques for thromboembolism, including the EkoSonic Endovascular System.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1364
Segmentation of Endovascular Treatment Devices Market-
By Product-
• Percutaneous Endovascular Aneurysm Repair (EVAR)
• Fenestrated EVAR
• Aortic Stents Biodegradable Stents
• Self-Expanding Nitinol Stents
• ThoracicAortic Aneurysm Grafts
• Other Devices
By Procedure-
• Ballon Angioplasty
• Angioplasty With Stent Replacement
• Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery
• Thrombosis
• Renal Artery Angioplasty and Stenting
• Transfemoral Carotid Artery Revascularization
• Intravascular Brachytherapy
• Carotid Artery Stenting
By Application-
• Pulmonary
• Vascular
• Cardiology Surgery
• Neurology
• Radiology
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
For More Information: https://www.insightaceanalytic.com/report/global-endovascular-treatment-devices-market-/1364
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Site Visit: www.insightaceanalytic.com
Email: info@insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endovascular Treatment Devices Market Exclusive Report on the Latest Revenue and Future Scope here
News-ID: 3341504 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
